Skip to content

Safety and Aesthetic Outcomes of Breast Conserving Surgery With Peri-areolar Incision Approach

Randomized Controlled Trial of Safety and Aesthetic Outcomes of Breast-conserving Surgery With the Peri-areolar Incision Approach

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01412788
Enrollment
100
Registered
2011-08-09
Start date
2007-01-31
Completion date
Unknown
Last updated
2011-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, Breast Conserving Surgery, Peri-areolar Incision

Brief summary

Cosmetic result after breast-conserving surgery (BCS) would impose great effect upon patient's quality of life. Although peri-areolar incision has been widely used in benign breast tumor excision, mastopexy procedures and skin-sparing mastectomy with primary reconstruction, the actual safety and aesthetic outcome of the peri-areolar incision approach in BCS for cancer patients has not been established by randomized, controlled trials. This trial was design to compare the Safety and aesthetic outcomes of breast conserving surgery between peri-areolar incision approach and traditional methods.

Detailed description

The Trial aims to determine whether BCS with the peri-areolar approach: 1) is safe in terms of the rates of recurrence and metastasis; 2) can improve the post-operative aesthetic score and QOL score.

Interventions

PROCEDUREperi-areolar incision

peri-areolar incision was used to carry out lumpectomy in breast-conserving surgery.

Traditional incision above tumor was used to carry out breast-conserving surgery.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients desire for breast conserving surgery; * fulfills criteria for breast conserving surgery; * the maximum diameter of the tumor should be less than the semi-perimeter of the areola and that the proximal margin of tumor should be at least 1 cm away from the areola; * patients suitable to receive BCS with either the peri-areolar incision or the traditional incision were included;

Exclusion criteria

* patients not suitable for breast conserving surgery; * skin or sub-cutaneous tumor invasion as definite contra-indication of skin-sparing; * male or bilateral breast cancers who might bring up bias in deciding aesthetic outcomes and expenditure; * Patients who were supposed to benefit from a certain kind of incision were also excluded at the researcher's discretion.

Design outcomes

Primary

MeasureTime frameDescription
event free survival5 yearslocal recurrence, regional recurrence, distant metastasis, death

Secondary

MeasureTime frameDescription
aesthetic outcomestwo weeks, half a year and one yearaesthetic score and QOL score
cost2 weeksoperation time for the surgery, hospital stay days, costs

Countries

China

Contacts

Primary ContactSun Qiang, Master
sunq@medmail.com.cn86-010-88068936
Backup ContactShen Songjie, Doctor
pumcssj@163.com86-010-88068936

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026